Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

about

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

Item

http://www.wikidata.org/entity/Q39036174

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@en

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@nl

type

Item

label

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@en

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@nl

prefLabel

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@en

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

@nl

P1476

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age

@en

P2093

Debra L Palazzi

http://www.w3.org/2001/XMLSchema#string

Janice E Sullivan

http://www.w3.org/2001/XMLSchema#string

Jeffrey Blumer

http://www.w3.org/2001/XMLSchema#string

Jennifer Murphy

http://www.w3.org/2001/XMLSchema#string

John S Bradley

http://www.w3.org/2001/XMLSchema#string

Kevin M Watt

http://www.w3.org/2001/XMLSchema#string

Laura P James

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Michael Cohen-Wolkowiez

http://www.w3.org/2001/XMLSchema#string

Michael W Dunne

http://www.w3.org/2001/XMLSchema#string

P2860

New equations to estimate GFR in children with CKD

Prediction of creatinine clearance from serum creatinine

Once-weekly dalbavancin versus daily conventional therapy for skin infection.

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection.

Mechanistic basis of using body size and maturation to predict clearance in humans.

Measurement and estimation of GFR in children and adolescents.

A pharmacokinetic standard for babies and adults.

Pharmacokinetics, Safety and Tolerability of Single Dose Dalbavancin in Children 12-17 Years of Age.

Human renal function maturation: a quantitative description using weight and postmenstrual age.

P304

645-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0000000000001538

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Gonzalez

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28060045

http://www.w3.org/2001/XMLSchema#string

P932

5468484

http://www.w3.org/2001/XMLSchema#string